Therapeutic targeting of ADAM8 with isoacteoside mitigates myocardial infarction injury via OPA1-mediated mitochondrial fusion dynamics

31 August 2026 (14:30 - 14:40)
Organised by: Logo
Congress Presentation Part of: Therapeutic targeting and cardiac repair strategies Mitochondria ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology